Bovine rotavirus (BRV) VI005 is serologically distinct from rotavirus serotypes 1, 2, 3, 4, 5, 6, 8 and 9. BRV VI005 showed cross-reactions with BRV B223, the American prototype of serotype 10 rotavirus, and with BRV E4049, a British serotype 10 isolate. BRV V1005 was, however, not neutralized by four monoclonal antibodies directed against VP7 of BRV B223. Twoway cross-reactions were observed between BRV VI005 and a reassortant rotavirus containing the VP4 from BRV UK. In addition the major tryptic cleavage product of VP4, VP5*, from BRV V1005 is indistinguishable by peptide mapping and its isoelectric point from the homologous protein of BRV UK, but is clearly different from VP5* of BRV NCDV. The peptide map of VP7 from BRV VI005 differed from that obtained for VP7 of BRV UK.
BachmannP. A.,
HessR. G.1981; Routine isolation and cultivation of bovine rotaviruses in cell culture. American Journal of Veterinary Research 42:2149–2150
BellinzoniR. C.,
BlackhallJ. O.,
MattionN. M.,
EstesM. K.,
SnodgrassD. R.,
LatorreJ. L.,
ScodellerE. A.1989; Serological characterization of bovine rotaviruses isolated from dairy and beef herds in Argentina. Journal of Clinical Microbiology 27:2619–2623
BenfieldD. A.,
NelsonE. A.,
HoshinoY.1987; A monoclonal antibody to the Gottfried strain of porcine rotavirus which neutralizes rotavirus serotypes 3, 4 and 6. Seventh International Congress of Virology Abstracts p. 111
BridgerJ. C.,
BrownJ. F.1984; Antigenic and pathogenic relationships of three bovine rotaviruses and a porcine rotavirus. Journal of General Virology 65:1151–1158
BrüssowH.,
BruttinA.,
Marc-MartinS.1990a; Polypeptide composition of rotavirus empty capsids and their possible use as a subunit vaccine. Journal of Virology 64:3635–3642
BrüssowH.,
OffitP. A.,
GernaG.,
BruttinA.,
SidotiJ.1990b; Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus. Journal of Virology 64:4130–4136
ClarkH,
HoshinoY.,
BellL. M.,
GroffJ.,
HessG.,
BachmannP.,
OffitP. A.1987; Rotavirus isolate WI 61 representing a presumptive new human serotype. Journal of Clinical Microbiology 25:1757–1762
ClarkS. M.,
RothJ. R.,
ClarkM. L.,
BarnettB. B.,
SpendloveR. S.1981; Trypsin enhancement of rotavirus infectivity: mechanism of enhancement. Journal of Virology 39:816–822
ClevelandD. W.,
FischerS. G.,
KirschnerM. W.,
LaemmliU. K.1977; Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. Journal of Biological Chemistry 252:1102–1106
CoulsonB. S.,
FowlerK. J.,
BishopR. F.,
CottonR. G.1985; Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. Journal of Virology 54:14–20
GernaG.,
SarasiniA.,
di MatteoA.,
PareaM.,
OrsoliniP.,
BattagliaM.1988; Identification of two subtypes of serotype 4 human rotavirus by using VP7-specific neutralizing monoclonal antibodies. Journal of Clinical Microbiology 26:1388–1392
GorzigliaM.,
GreenK.,
NishikawaK.,
TaniguchiK.,
JonesR.,
KapikianA. Z.,
ChanockR. M.1988; Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. Journal of Virology 62:2978–2984
GreenbergH. B.,
FloresJ.,
KalicaA. R.,
WyattR. G.,
JonesR.1983; Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. Journal of General Virology 64:313–320
HoshinoY.,
SerenoM. M.,
MidthunK.,
FloresJ.,
KapikianA. Z.,
ChanockR. M.1985; Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proceedings of the National Academy of Sciences, U.S.A 82:8701–8704
MackowE. R.,
ShawR. D.,
MatsuiS. M.,
VoP. T.,
BenfieldD. A.,
GreenbergH. B.1988; Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology 165:511–517
PetersK. E.,
ComingsD. E.1980; Two-dimensional gel electrophoresis of rat liver nuclear washes, nuclear matrix, and hn RNA proteins. Journal of Cell Biology 86:135–155
ShawR. D.,
Stoner-MaD. L.,
EstesM. K.,
GreenbergH. B.1985; Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. Journal of Clinical Microbiology 22:286–291
SnodgrassD. R.,
OjehC. K.,
CampbellI.,
HerringA. J.1984; Bovine rotavirus serotypes and their significance for immunization. Journal of Clinical Microbiology 20:342–346
SnodgrassD. R.,
FitzgeraldT.,
CampbellI.,
ScottF. M. M.,
BrowningG. F.,
MillerD. L.,
HerringA. J.,
GreenbergH. B.1990; Rotavirus serotypes 6 and 10 predominate in cattle. Journal of Clinical Microbiology 28:504–507
TaniguchiK.,
NishikawaK.,
UrasawaT.,
UrasawaS.,
MidthunK.,
KapikianA. Z.,
GorzigliaM.1989; Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes. Journal of Virology 63:4101–4106
WoodeG. N.,
KelsoN. E.,
SimpsonT. R.,
GaulS. K.,
EvansL. E.,
BabiukL.1983; Antigenic relationship among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves. Journal of Clinical Microbiology 118:358–364
WyattR. G.,
JamesH. D.,
PittmanA. L.,
HoshinoY.,
GreenbergH. B.,
KalicaA. R.,
FloresJ.,
KapikianA. Z.1983; Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. Journal of Clinical Microbiology 18:310–317
ZhengS.,
WoodeG. N.,
MelendyD. R.,
RamigR. F.1989; Comparative studies of the antigenic polypeptide species VP4, VP6 and VP7 of three strains of bovine rotavirus. Journal of Clinical Microbiology 27:1939–1945